Page last updated: 2024-10-31

naftopidil and Ureteral Calculi

naftopidil has been researched along with Ureteral Calculi in 10 studies

Ureteral Calculi: Stones in the URETER that are formed in the KIDNEY. They are rarely more than 5 mm in diameter for larger renal stones cannot enter ureters. They are often lodged at the ureteral narrowing and can cause excruciating renal colic.

Research Excerpts

ExcerptRelevanceReference
" Naftopidil was not only effective for distal ureteral calculi but also was comparable to tamsulosin in efficacy."4.95Efficacy and Safety of Naftopidil in the Medical Expulsion Therapy for Distal Ureteral Stone: A Systematic Review and Meta-Analysis. ( Gao, L; Li, J; Qin, F; Tang, Z; Yuan, J, 2017)
"Using anesthesia the effects of silodosin and naftopidil were evaluated by the phenylephrine induced increase in intravesical ureteral pressure and on blood pressure."3.76Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage. ( Hoyano, Y; Kobayashi, S; Kohri, K; Sasaki, S; Tomiyama, Y; Yamazaki, Y, 2010)
"Treatment with naftopidil and tolterodine appears to be beneficial in intramural ureteral stones clearance, particularly in the intramural ureter with symptoms of vesical irritability."2.77Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study. ( De Liu, F; Hui, JH; Lu, JL; Tang, QL, 2012)
"Naftopidil is a specific alpha1D-adrenergic receptor antagonist."2.74Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. ( Ge, W; He, L; Lv, J; Sun, X, 2009)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's9 (90.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, SY1
Na, W1
Lee, SW1
Cho, MC1
Oh, JJ1
Lee, S1
Park, J1
Ahn, S1
Jeong, CW1
Kohjimoto, Y1
Hagino, K1
Ogawa, T1
Inagaki, T1
Kitamura, S1
Nishihata, M1
Iba, A1
Matsumura, N1
Hara, I1
Li, J2
Tang, Z1
Gao, L1
Qin, F1
Yuan, J1
Sun, X1
He, L1
Ge, W1
Lv, J1
Kobayashi, S1
Tomiyama, Y1
Hoyano, Y1
Yamazaki, Y1
Sasaki, S1
Kohri, K1
Nirmal, TJ1
Ohgaki, K1
Horiuchi, K1
Hikima, N1
Kondo, Y1
Zhou, SG1
Lu, JL2
Hui, JH2
Tsuzaka, Y1
Matsushima, H1
Kaneko, T1
Yamaguchi, T1
Homma, Y1
Tang, QL1
De Liu, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Silodosin vs. Tamsulosin on Spontaneous Passage of Acutely Obstructing Ureteral Calculi in Medical Expulsive Therapy[NCT02369744]Phase 41 participants (Actual)Interventional2013-03-31Terminated (stopped due to due to lack of suitable patient population)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for naftopidil and Ureteral Calculi

ArticleYear
Efficacy and Safety of Naftopidil in the Medical Expulsion Therapy for Distal Ureteral Stone: A Systematic Review and Meta-Analysis.
    Journal of endourology, 2017, Volume: 31, Issue:5

    Topics: Adrenergic alpha-Antagonists; Cost-Benefit Analysis; Female; Humans; Male; Naphthalenes; Odds Ratio;

2017

Trials

6 trials available for naftopidil and Ureteral Calculi

ArticleYear
Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial.
    World journal of urology, 2015, Volume: 33, Issue:12

    Topics: Adrenergic alpha-Antagonists; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphtha

2015
Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones.
    The Journal of urology, 2009, Volume: 181, Issue:4

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Female; Humans; Male; Middle Aged; Naphthalen

2009
Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.
    Scandinavian journal of urology and nephrology, 2010, Volume: 44, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Drug Therapy, Combinat

2010
Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.
    World journal of urology, 2011, Volume: 29, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Naphtha

2011
Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.
    International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:11

    Topics: Adrenergic alpha-Antagonists; Adult; Humans; Indoles; Japan; Lithotripsy; Male; Middle Aged; Naphtha

2011
Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study.
    Urological research, 2012, Volume: 40, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Femal

2012

Other Studies

3 other studies available for naftopidil and Ureteral Calculi

ArticleYear
Medical expulsive therapy for ureter stone using naftopidil: A multicenter, randomized, double-blind, and placebo-controlled trial.
    PloS one, 2017, Volume: 12, Issue:4

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Placebos;

2017
Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage.
    The Journal of urology, 2010, Volume: 183, Issue:1

    Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Cardiovascular System; Dogs; Dose-Response Relati

2010
Re: Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. X. Sun, L. He, W. Ge and J. Lv. J Urol 2009; 181: 1716-1720.
    The Journal of urology, 2010, Volume: 183, Issue:3

    Topics: Adrenergic alpha-Antagonists; Humans; Naphthalenes; Piperazines; Remission Induction; Ureteral Calcu

2010